Rashid, S. Tamir
Lomas, David A.
Article History
First Online: 8 March 2017
Competing interests
: D.A.L. is funded by the Engineering and Physical Science Research Council, GlaxoSmithKline, the Medical Research Council, the Rosetrees Trust, the University College London Hospital National Institute for Health Research Biomedical Research Centre, and the Wellcome Trust. He is working with GlaxoSmithKline to develop small molecules that block the intracellular polymerization of α<sub>1</sub>-antitrypsin. S.T.R. is funded by the Medical Research Council and holds shares as a co-scientific founder in the company DefiniGen.